AAF
HZNP

Andra AP-fonden’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Andra AP-fonden’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-78,100
Closed -$9.04M – 259
2023
Q3 		$9.04M Sell
78,100
-55,100
-41% -$5.92M 0.53% 59
2023
Q2 		$13.7M Buy
133,200
+5,800
+5% +$612K 0.35% 23
2023
Q1 		$13.9M Buy
127,400
+44,700
+54% +$4.94M 0.36% 33
2022
Q4 		$9.41M Sell
82,700
-12,400
-13% -$1.03M 0.29% 75
2022
Q3 		$5.89M Buy
95,100
+61,700
+185% +$4.31M 0.19% 229
2022
Q2 		$2.66M Buy
+33,400
New +$3.16M 0.08% 476
2021
Q4 		$6.25M Sell
58,000
-10,200
-15% -$1.11M 0.13% 365
2021
Q3 		$7.47M Buy
68,200
+13,500
+25% +$1.4M 0.15% 324
2021
Q2 		$5.12M Sell
54,700
-21,400
-28% -$1.97M 0.1% 436
2021
Q1 		$7M Sell
76,100
-27,000
-26% -$2.28M 0.15% 326
2020
Q4 		$7.54M Buy
+103,100
New +$7.66M 0.17% 300

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Andra AP-fonden's HZNP Position: Q4 2023 in Review

Andra AP-fonden sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 78,100 shares — an estimated $9.04M sold.

Andra AP-fonden first reported a position in HZNP in Q4 2020 and held it in 11 quarters. The position peaked at $13.9M in Q1 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Andra AP-fonden reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Andra AP-fonden sold 78,100 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $9.04M.
  • Andra AP-fonden first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and held it in 11 quarters.
  • Andra AP-fonden's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $13.9M in Q1 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Andra AP-fonden's 13F filing for Q4 2023, filed 15 Feb 2024.